A generic steroid drug is the first to show in a clinical trial it could improve the survival of severely ill coronavirus patients, University of Oxford researchers said
The treatment, dexamethasone, is the first drug to show in a clinical trial it could improve the survival of severely ill coronavirus patients, the researchers said.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Cheap, widely available steroid called dexamethasone improves COVID survival, researchers sayA cheap, widely available steroid called dexamethasone reduced deaths by up to one third in severely ill hospitalized patients.
Lire la suite »
COVID-19 cases haven't deterred college football's quest to return, but when would they?As players return to campuses and the season looks more likely, positive COVID-19 tests are a reminder of the challenges college football still faces.
Lire la suite »
Florida Hits Biggest Daily COVID-19 Jump As It Gears Up For GOP ConventionFlorida coronavirus cases jumped 35% Saturday over the previous day, smashing a single-day record just as state officials are gearing up to host thousands of visitors for major events of the Republican National Convention in August
Lire la suite »
UK COVID-19 death toll rises by 36, lowest daily tally during lockdownThe United Kingdom's death toll from confirmed cases of COVID-19 rose by 36 to 41,698 as of 1600 GMT on June 13, government data showed on Sunday.
Lire la suite »
Medical bias: From pain pills to COVID-19, racial discrimination in health care festersWhether it's unconscious, explicit, institutional or research bias, discrimination in the health care system contributes to the stark disparities seen in how COVID-19 sickens and kills patients of color.
Lire la suite »